PVLA – palvella therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at Craig Hallum. They set a "buy" rating on the stock.
Palvella Therapeutics (NASDAQ:PVLA) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
Palvella Therapeutics (NASDAQ:PVLA) was given a new $145.00 price target on by analysts at Stifel Nicolaus.
Palvella Therapeutics (NASDAQ:PVLA) was upgraded by analysts at Raymond James Financial, Inc. from an "outperform" rating to a "strong-buy" rating. They now have a $143.00 price target on the stock, up previously from $92.00.
Palvella Therapeutics (NASDAQ:PVLA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $90.00 to $148.00. They now have a "buy" rating on the stock.
Form 4 PALVELLA THERAPEUTICS, For: Nov 19 Filed by: Goin Kathleen
Form 144 PALVELLA THERAPEUTICS, Filed by: Goin Kathleen
Form SCHEDULE 13G/A PALVELLA THERAPEUTICS, Filed by: BIOTECHNOLOGY VALUE FUND L P
Form 10-Q PALVELLA THERAPEUTICS, For: Sep 30
Form 8-K PALVELLA THERAPEUTICS, For: Nov 10
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.